Posted in | News | Chemical Sensor

Implant Sciences Receives $500,000 Follow-On Order from Kuehne + Nagel for QS-B220 Explosives Trace Detectors

Implant Sciences Corporation, a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced today it has shipped a follow-on order for approximately $500,000 of its QS-B220 explosives trace detectors to Kuehne + Nagel, one of the worlds' leading logistics companies.

The QS-B220s will be deployed across a total of ten facilities for air cargo screening in the U.S. This order follows the customer's initial order in 2014.

"We were very pleased to receive this follow on order, which is more than twice the size of the first purchase by one of the largest logistics companies in the world. Based on feedback we've received from Kuehne +Nagel the factors driving their decision included the favorable low cost of maintenance for our systems, as compared with the competing systems being replaced by our QS-B220s. Remote diagnostics and push-button maintenance also reduced both down-time and maintenance expenses for our customer," stated Dr. Darryl Jones, Vice President, Global Sales and Marketing.

About the QS-B220 Desktop Explosives and Drugs Trace Detector

The QS-B220 uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives as well as illicit drugs. With significantly lower maintenance requirements than competing systems, the QS-B220 can be deployed for a much lower total cost of ownership than other approved products. Featuring a radioactive material-free design, push-button maintenance and diagnostics, and a patented inCal™ internal automatic calibration system, the QS-B220 brings new levels of performance and convenience to desktop trace detection users with unsurpassed ease of use.

About Implant Sciences

Implant Sciences is a leader in developing and manufacturing advanced detection capabilities to counter and eliminate the ever-evolving threats from explosives and drugs. The company's team of dedicated explosives trace detection (or ETD) experts has developed patented technologies used in its commercial products, thousands of which have been sold across more than 50 countries worldwide. The company's ETDs have received approvals and certifications from several international regulatory agencies including the TSA in the U.S., STAC in France, the German Ministry of the Interior, and the Ministry of Public Safety in China. It also received a GSN 2013 Homeland Security Award for "Best Explosives Detection Solution". All Implant Sciences products are recognized as Qualified Anti-Terrorism Technologies by the Department of Homeland Security. For further details on the company and its products, please visit the company's website.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    L3Harris Technologies, Inc.. (2019, February 24). Implant Sciences Receives $500,000 Follow-On Order from Kuehne + Nagel for QS-B220 Explosives Trace Detectors. AZoSensors. Retrieved on November 21, 2024 from https://www.azosensors.com/news.aspx?newsID=9425.

  • MLA

    L3Harris Technologies, Inc.. "Implant Sciences Receives $500,000 Follow-On Order from Kuehne + Nagel for QS-B220 Explosives Trace Detectors". AZoSensors. 21 November 2024. <https://www.azosensors.com/news.aspx?newsID=9425>.

  • Chicago

    L3Harris Technologies, Inc.. "Implant Sciences Receives $500,000 Follow-On Order from Kuehne + Nagel for QS-B220 Explosives Trace Detectors". AZoSensors. https://www.azosensors.com/news.aspx?newsID=9425. (accessed November 21, 2024).

  • Harvard

    L3Harris Technologies, Inc.. 2019. Implant Sciences Receives $500,000 Follow-On Order from Kuehne + Nagel for QS-B220 Explosives Trace Detectors. AZoSensors, viewed 21 November 2024, https://www.azosensors.com/news.aspx?newsID=9425.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.